Diabetes 文獻一篇

bjouxz

Diabetes. 2016 Jan;65(1):269-75. doi: 10.2337/db15-0893. Epub 2015 Oct 15.
3 b8 a7 [, J  n) v: \( p- q2 |The Glucagon-Like Peptide 1 Receptor Agonist Exenatide Inhibits Small Intestinal Motility, Flow, Transit, and Absorption of Glucose in Healthy Subjects and Patients With Type 2 Diabetes: A Randomized Controlled Trial.
4 D" O- X; a$ g2 ~Thazhath SS1, Marathe CS1, Wu T1, Chang J1, Khoo J1, Kuo P2, Checklin HL1, Bound MJ1, Rigda RS1, Crouch B3, Jones KL1, Horowitz M1, Rayner CK43 }: K9 I! K, i; B: r9 h/ G

" H6 _5 D* E' Z, E, NLink: http://diabetes.diabetesjournals.org/content/65/1/269.long 9 W6 Q/ P& }: \" \

* m9 P' K$ e- I/ h. C: o" d! QThanks so much!

farui

The Glucagon-Like Peptide 1 Receptor Agonist Exenatide Inhibits Small Intestinal Motility, Flow, Transit, and Absorption of Glucose in Healthy Subjects and Patients With Type 2 Diabetes: A Randomized Controlled Trial2 P# F1 F  K- J* R